PFE relationship map
PFE
Pfizer Inc
PFE buys from Healthcare · 12
Healthcare12 · open
Nektar TherapeuticsNKTR12.00% of NKTR revNKTR 10-K
2°UCBunlisted
2°Baxalta (a subsidiary of Takeda Pharmaceutical Company Limited)unlisted
Adaptive BiotechnologiesADPTArvinasARVN2°Bayerunlisted
2°Yale Universityunlisted
Beam TherapeuticsBEAMBioNTechBNTXCaribou BiosciencesCRBU2°Edge Animal Healthunlisted
2°ProMab Biotechnologiesunlisted
Nurix TherapeuticsNRIX2°Silicon Valley Bank (SVB)unlisted
NovavaxNVAXOpko HealthOPKProtalix BioTherapeuticsPLX2°Fiocruzunlisted
2°Brazilian MoHunlisted
2°Chiesiunlisted
Serina TherapeuticsSERSpero TherapeuticsSPRO2°Bardaunlisted
2°Meijiunlisted
Industrials & materials2 ›← Buys from
PFEPfizer Inc
12.00% of NKTR rev10-K
2°UCBunlisted
2°Baxalta (a subsidiary of Takeda Pharmaceutical Company Limited)unlisted
2°Bayerunlisted
2°Yale Universityunlisted
2°Edge Animal Healthunlisted
2°ProMab Biotechnologiesunlisted
2°Silicon Valley Bank (SVB)unlisted
2°Fiocruzunlisted
2°Brazilian MoHunlisted
2°Chiesiunlisted
2°Bardaunlisted
2°Meijiunlisted
← Buys from
PFEPfizer Inc
2°Pharmanoviaunlisted
2°Merck KGaAunlisted
2°Betta Pharmaunlisted
2°Pursuit Vascularunlisted
2°Smiths Medical 2020unlisted
2°Gregory Pharmaceutical Holdings, Inc. (d/b/a UPM Pharmaceuticals)unlisted
2°Customer Aunnamed in filing
2°Rocheunlisted
2°Shire International GmbH (Takeda Pharmaceutical Company Limited)unlisted
2°Lonzaunlisted
2°Black Shadow Therapeuticsunlisted
2°Aurigene Oncologyunlisted
2°Pint Pharma Internationalunlisted
2°Knight Therapeuticsunlisted
2°Pierre Fabre Medicament SASunlisted
2°Simcereunlisted
2°Biosion USAunlisted
2°Bardaunlisted
2°Meijiunlisted
Sells to →
suppliercustomer2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 20:25 ETSources